Pharma
Page: 3
Global data is key to tackling the rise in brain health conditions
Will the Commission blink under pressure from pharma? We’re about to find out
The real reason Europe’s medicines industry is dying
By the numbers: European drugmakers stuck between a dominant US and a rising China
Can Europe afford the next generation of medicines?
Germany scales back cannabis legalization plans to focus on home cultivation
How Big Pharma games the system — and keeps drugs prices high
Layers of market protections and courtroom tricks keep competitors off the market far longer than rules intended, say generics firms.
Committee of the absurd: EU Parliament scrutinizes pharma plan that doesn’t exist
Hearing with commissioner turned into a tragicomedy.
Europe’s coronavirus vaccine glut leads to call for contract transparency
Countries want a ‘new, fairer deal’ with Pfizer.
Waiting in the wings: Why bird flu vaccines are a game-time decision
Europe is experiencing its largest-ever avian flu outbreak in birds.
EU transparency commissioner: No conflict of interest for Ursula von der Leyen’s husband
Green lawmakers had raised concerns about Heiko von der Leyen’s role in a biotech company that received EU funds.
AI is about to remake the pharmaceutical industry
Algorithm-designed drugs are entering human trials.
In Amsterdam, EU drugs regulator doesn’t want brothel moving in next door
Sex and drugs don’t mix, argues the EMA.
New York Times sues EU over von der Leyen’s Pfizer texts
The messages could shed light on deals to buy billions of euros worth of COVID-19 vaccines.
The EU butts heads with Big Pharma to make medicines cheaper
The bloc’s pharma reform aims to get new drugs to patients faster, for less money. But it clashes with the industry’s priorities.
Europe is running out of medicines
Common medications including antibiotics and children’s painkillers are in short supply across the bloc. Here’s what’s being done about it.
UK medicines tax forcing cheaper drugs off the market
Generic and biosimilar medicines manufacturers warn the UK is no longer a viable market after a 26.5 percent rebate hike.
Everything you wanted to know about the EU’s pharma reform (but were too afraid to ask)
We break down the EU’s planned overhaul of its pharma regulation.
MEPs want to grill von der Leyen over Pfizer vaccine contract
The European Parliament’s COVID-19 committee will ask the European Commission president to appear before the panel.
Once-favored COVID drugs ineffective on Omicron may be putting millions at risk
While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.
Bitter pills: Europe and Ukraine divided over pharma sanctions
Kyiv wants to punish some European drugmakers still working in Russia.
Von der Leyen’s COVID vaccine deal comes under fire from EU capitals
‘What was promised? We would really like to know,’ said one Belgian official.
Pfizer boss refuses to testify to EU Parliament COVID panel — again
‘We have no further information to share,’ says Albert Bourla, who bailed out of an earlier appointment in October.
Germany to China: Use Western vaccines, duh
Government spokesperson suggests Beijing should start using Western mRNA jabs to get out of the pandemic.
Confronting the world’s number one killer: cardiovascular disease
POLITICO Studio spoke to members of the Council for Heart Health, an inclusive group of experts committed to reducing the burden of cardiovascular disease through multidisciplinary collaboration.
A new pandemic playbook: Draft treaty sets out far-reaching new rules for countries
Countries would need to make significant commitments to ensure equitable access to medical products.
Who killed the COVID vaccine waiver?
The inside story of how lobbying, threats and the desire to protect industry gutted a proposal that was meant to make vaccines widely available in poorer countries.
Scholz’s China visit secures BioNTech/Pfizer vaccine access for expats
German chancellor says this would be a ‘first step’ toward wider use of the vaccine.
After Roe, abortion’s underground railroad gains steam
A network of activists is helping women terminate pregnancies in countries where the procedure is banned.